Dianthus Therapeutics (DNTH) Interest & Investment Income (2017 - 2025)
Dianthus Therapeutics' (DNTH) quarterly Interest & Investment Income came in at $1.3 million in Q3 2025, down 69.7% year-on-year from $4.4 million in Q3 2024, and up 883.14% quarter-over-quarter from -$172000.0 in Q2 2025.
Dianthus Therapeutics (DNTH) Interest & Investment Income (2017 - 2025) Analysis & Trends
Dianthus Therapeutics' Interest & Investment Income history runs 9 years deep, the most recent figure standing at $1.3 million for Q3 2025.
- On a quarterly basis, Interest & Investment Income fell 69.7% year-over-year to $1.3 million in Q3 2025; TTM through Sep 2025 was $8.6 million, a 282.84% increase from a year earlier, with the FY2024 full-year figure at $17.4 million, up 8248.56% from the prior year.
- Interest & Investment Income improved to $1.3 million in Q3 2025 per DNTH's latest filing, from -$172000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $7.3 million in Q4 2024 and bottomed at -$2.7 million in Q4 2021.
- The 5-year median for Interest & Investment Income is $38000.0 (2023), against an average of $586421.1.
- Across the five-year window, Interest & Investment Income plunged 4279.03% in 2021 and surged 444.27% in 2024, its largest moves.
- Year by year, Interest & Investment Income stood at -$2.7 million in 2021, then jumped by 123.57% to $640000.0 in 2022, then sank by 430.0% to -$2.1 million in 2023, then jumped by 444.27% to $7.3 million in 2024, then tumbled by 81.47% to $1.3 million in 2025.
- Per Business Quant, the three latest DNTH Interest & Investment Income figures stand at $1.3 million (Q3 2025), -$172000.0 (Q2 2025), and $164000.0 (Q1 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 44.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 19.51 Mn |
| 10 | Dianthus Therapeutics | 3.92 Bn | 3.51 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.35 Mn |
| Jun 30, 2025 | -172,000.00 |
| Mar 31, 2025 | 164,000.00 |
| Dec 31, 2024 | 7.27 Mn |
| Sep 30, 2024 | 4.45 Mn |
| Jun 30, 2024 | -10,000.00 |
| Mar 31, 2024 | -74,000.00 |
| Dec 31, 2023 | -2.11 Mn |
| Sep 30, 2023 | 1.03 Mn |
| Jun 30, 2023 | 38,000.00 |
| Mar 31, 2023 | 606,000.00 |
| Dec 31, 2022 | 640,000.00 |
| Sep 30, 2022 | 416,000.00 |
| Jun 30, 2022 | -133,000.00 |
| Mar 31, 2022 | -439,000.00 |
| Dec 31, 2021 | -2.72 Mn |
| Sep 30, 2021 | 818,000.00 |
| Jun 30, 2021 | -7,000.00 |
| Mar 31, 2021 | 32,000.00 |
| Dec 31, 2020 | -62,000.00 |